Lupus clue: can a heart drug reveal hidden disease markers?
NCT ID NCT02320357
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study looked at whether clopidogrel, a drug that stops blood clots, could lower a substance called sCD40L in people with lupus. Lupus is an autoimmune disease where the body attacks itself. The study involved 18 adults with lupus and measured sCD40L levels in their blood. The goal was to learn more about the disease, not to treat it directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Médecine Interne
Limoges, 87000, France
-
Service de Médecine Interne et Immunopathologie
Toulouse, 31 000, France
-
Service de Médecine Interne et maladies Infectieuses - Hôpital Saint-André
Bordeaux, Bordeaux, 33075, France